Evaluation of mobilized peripheral blood CD34⁺ cells from patients with severe coronary artery disease as a source of endothelial progenitor cells

References

• Peichev M, Naiyer AJ, Pereira D, Zhu Z, Lane WJ, Williams M, . Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood. 2000;95:952–8.
   PubMed Web of Science ®Google Scholar
• Verfaillie CM, Pera MF, Lansdorp PM. Stem cells: hype and reality. Hematology (Am Soc Hematol Educ Program). 2002:369–91.
   Google Scholar
• Zubair AC, Silberstein L, Ritz J. Adult hematopoietic stem cell plasticity. Transfusion. 2002;42:1096–101.
   Google Scholar
• Eichmann A, Corbel C, Nataf V, Vaigot P, Breant C, Le Douarin NM. Ligand-dependent development of the endothelial and hemopoietic lineages from embryonic mesodermal cells expressing vascular endothelial growth factor receptor 2. Proc Natl Acad Sci, USA (PNAS). 1997;94:5141–6.
   PubMed Web of Science ®Google Scholar
• Choi K, Kennedy M, Kazarov A, Papadimitriou JC, Keller G. A common precursor for hematopoietic and endothelial cells. Development. 1998;125:725–32.
   PubMed Web of Science ®Google Scholar
• Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, . Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997;275:964–7.
   PubMed Web of Science ®Google Scholar
• George J, Shmilovich H, Deutsch V, Miller H, Keren G, Roth A. Comparative analysis of methods for assessment of circulating endothelial progenitor cells. Tissue Eng. 2006;12:331–5.
   PubMedGoogle Scholar
• Rafii S, Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med. 2003;9:702–12.
   PubMed Web of Science ®Google Scholar
• Hristov M, Erl W, Weber PC. Endothelial progenitor cells: mobilization, differentiation, and homing. Arterioscl Thromb Vasc Biol. 2003;23:1185–9.
   PubMed Web of Science ®Google Scholar
• Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, . Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med. 2003;348:593–600.
   PubMed Web of Science ®Google Scholar
• Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H, . Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res. 2001;89:E1–7.
   PubMed Web of Science ®Google Scholar
• Simper D, Wang S, Deb A, Holmes D, McGregor C, Frantz R, . Endothelial progenitor cells are decreased in blood of cardiac allograft patients with vasculopathy and endothelial cells of noncardiac origin are enriched in transplant atherosclerosis. Circulation. 2003;108:143–9.
   PubMed Web of Science ®Google Scholar
• George J, Herz I, Goldstein E, Abashidze S, Deutch V, Finkelstein A, . Number and adhesive properties of circulating endothelial progenitor cells in patients with in-stent restenosis. Arterioscl Throm Vasc Biol. 2003;23:E57–60.
   PubMed Web of Science ®Google Scholar
• Tepper OM, Galiano RD, Capla JM, Kalka C, Gagne PJ, Jacobowitz GR, . Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation. 2002;106:2781–6.
   PubMed Web of Science ®Google Scholar
• Takahashi T, Kalka C, Masuda H, Chen D, Silver M, Kearney M, . Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med. 1999;5:434–8.
   PubMed Web of Science ®Google Scholar
• Shintani S, Murohara T, Ikeda H, Ueno T, Honma T, Katoh A, . Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation. 2001;103:2776–9.
   PubMed Web of Science ®Google Scholar
• Gill M, Dias S, Hattori K, Rivera ML, Hicklin D, Witte L, . Vascular trauma induces rapid but transient mobilization of VEGFR2(+)AC133(+) endothelial precursor cells. Circ Res. 2001;88:167–74.
   PubMed Web of Science ®Google Scholar
• George J, Goldstein E, Abashidze S, Deutsch V, Shmilovich H, Finkelstein A, . Circulating endothelial progenitor cells in patients with unstable angina: association with systemic inflammation. Eur Heart J. 2004;25:1003–8.
   PubMed Web of Science ®Google Scholar
• Llevadot J, Murasawa S, Kureishi Y, Uchida S, Masuda H, Kawamoto A, . HMG-CoA reductase inhibitor mobilizes bone marrow-derived endothelial progenitor cells. J Clin Invest. 2001;108:399–405.
   PubMed Web of Science ®Google Scholar
• Vasa M, Fichtlscherer S, Adler K, Aicher A, Martin H, Zeiher AM, . Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation. 2001;103:2885–90.
   PubMed Web of Science ®Google Scholar
• Kalka C, Masuda H, Takahashi T, Gordon R, Tepper O, Gravereaux E, . Vascular endothelial growth factor(165) gene transfer augments circulating endothelial progenitor cells in human subjects. Circ Res. 2000;86:1198–202.
   PubMed Web of Science ®Google Scholar
• Harper SJ, Bates DO. VEGF-A splicing: the key to anti-angiogenic therapeutics? Nat Rev Cancer. 2008;8:880–7.
   PubMed Web of Science ®Google Scholar
• Klagsbrun M, D'Amore PA. Vascular endothelial growth factor and its receptors. Cyto Grow Fact Rev. 1996;7:259–70.
   PubMedGoogle Scholar
• Serefhanoglu S, Goker H, Buyukasik Y, . Changes in vascular endothelial growth factor, angiopoietins, and Tie-2 levels with G-CSF stimulation in healthy donors. Ann Hematol. 2009;88:667–671.
   Google Scholar
• Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med. 2000;6:389–95.
   PubMed Web of Science ®Google Scholar
• Fong GH, Rossant J, Gertsenstein M, Breitman ML. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature. 1995;376:66–70.
   PubMed Web of Science ®Google Scholar
• Ortega N, Jonca F, Vincent S, Favard C, Ruchoux MM, Plouet J. Systemic activation of the vascular endothelial growth factor receptor KDR/flk-1 selectively triggers endothelial cells with an angiogenic phenotype. Am J Pathol. 1997;151:1215–24.
   PubMed Web of Science ®Google Scholar
• Gallacher L, Murdoch B, Wu DM, Karanu FN, Keeney M, Bhatia M. Isolation and characterization of human CD34(−) Lin(−) and CD34(+)Lin(−) hematopoietic stem cells using cell surface markers AC133 and CD7. Blood. 2000; 95:2813–20.
   PubMed Web of Science ®Google Scholar
• Yin AH, Miraglia S, Zanjani ED, Almeida-Porada G, Ogawa M, Leary AG, . AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood. 1997;90:5002–12.
   PubMed Web of Science ®Google Scholar
• Gehling UM, Ergun S, Schumacher U, Wagener C, Pantel K, Otte M, . In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood. 2000;95:3106–12.
   PubMed Web of Science ®Google Scholar
• Gering M, Patient R. Notch in the niche. Cell Stem cell. 2008;2:293–4.
   Google Scholar
• Ahmad S, Hewett PW, Wang P, Al-Ani B, Cudmore M, Fujisawa T, . Direct evidence for endothelial vascular endothelial growth factor receptor-1 function in nitric oxide-mediated angiogenesis. Circ Res. 2006;99:715–22.
   PubMed Web of Science ®Google Scholar
• Morbidelli L, Donnini S, Ziche M. Role of nitric oxide in the modulation of angiogenesis. Curr Pharm Des. 2003;9:521–30.
   PubMedGoogle Scholar
• Kondo T, Kobayashi K, Murohara T. Nitric oxide signaling during myocardial angiogenesis. Mol Cell Biochem. 2004;264:25–34.
   Google Scholar
• Orford KW, Scadden DT. Deconstructing stem cell self-renewal: genetic insights into cell-cycle regulation. Nat Rev Genet. 2008;9:115–28.
   PubMed Web of Science ®Google Scholar
• Plett PA, Frankovitz SM, Orschell-Traycoff CM. In vivo trafficking, cell cycle activity, and engraftment potential of phenotypically defined primitive hematopoietic cells after transplantation into irradiated or nonirradiated recipients. Blood. 2002;100:3545–52.
   PubMedGoogle Scholar
• Petit I, Szyper-Kravitz M, Nagler A, Lahav M, Peled A, Habler L, . G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat Immunol. 2002;3:687–94.
   PubMed Web of Science ®Google Scholar
• Jin F, Zhai Q, Qiu L, Meng H, Zou D, Wang Y, . Degradation of BM SDF-1 by MMP-9: the role in G-CSF-induced hematopoietic stem/progenitor cell mobilization. Bone Marrow Transplant. 2008;42:581–8.
   Google Scholar
• Kuethe F, Krack A, Fritzenwanger M, Herzau M, Opfermann T, Pachmann K, . Treatment with granulocyte-colony stimulating factor in patients with acute myocardial infarction. Evidence for a stimulation of neovascularization and improvement of myocardial perfusion. Die Pharmazie. 2006;61:957–61.
   PubMed Web of Science ®Google Scholar
• Ohki Y, Heissig B, Sato Y, Akiyama H, Zhu Z, Hicklin DJ, . Granulocyte colony-stimulating factor promotes neovascularization by releasing vascular endothelial growth factor from neutrophils. FASEB J. 2005;19:2005–7.
   PubMed Web of Science ®Google Scholar
• Sutherland DR, Anderson L, Keeney M, Nayar R, Chin-Yee I. The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering. J Hematother. 1996;5:213–26.
   PubMedGoogle Scholar
• Chen L, Necela BM, Su W, Yanagisawa M, Anastasiadis PZ, Fields AP, . Peroxisome proliferator-activated receptor gamma promotes epithelial to mesenchymal transformation by Rho GTPase-dependent activation of ERK1/2. J Biol Chem. 2006;281:24575–87.
   PubMed Web of Science ®Google Scholar
• Tura O, Barclay GR, Roddie H, Davies J, Turner ML. Absence of a relationship between immunophenotypic and colony enumeration analysis of endothelial progenitor cells in clinical haematopoietic cell sources. J Transl Med. 2007;5:37.
   Google Scholar
• Baum CM, Weissman IL, Tsukamoto AS, Buckle AM, Peault B. Isolation of a candidate human hematopoietic stem-cell population. Proc Natl Acad Sci USA. 1992;89:2804–8.
   PubMed Web of Science ®Google Scholar
• Bonanno G, Mariotti A, Procoli A, Corallo M, Rutella S, Pessina G, . Human cord blood CD133+ cells immunoselected by a clinical-grade apparatus differentiate in vitro into endothelial- and cardiomyocyte-like cells. Transfusion. 2007;47:280–9.
   Google Scholar
• Timmermans F, Van Hauwermeiren F, De Smedt M, Raedt R, Plasschaert F, De Buyzere ML, . Endothelial outgrowth cells are not derived from CD133+ cells or CD45+ hematopoietic precursors. Arterioscl Thromb Vasc Biol. 2007;27:1572–9.
   PubMed Web of Science ®Google Scholar
• Case J, Mead LE, Bessler WK, Prater D, White HA, Saadatzadeh MR, . Human CD34+AC133+ VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors. Exp Hematol. 2007;35:1109–18.
   PubMed Web of Science ®Google Scholar
• Daub K, Langer H, Seizer P, Stellos K, May AE, Goyal P, . Platelets induce differentiation of human CD34+ progenitor cells into foam cells and endothelial cells. FASEB J. 2006;20:2559–61.
   PubMedGoogle Scholar
• Langer H, May AE, Daub K, Heinzmann U, Lang P, Schumm M, . Adherent platelets recruit and induce differentiation of murine embryonic endothelial progenitor cells to mature endothelial cells in vitro. Circ Res. 2006;98:E2–10.
   Web of Science ®Google Scholar
• Pomyje J, Zivny J, Sefc L, Plasilova M, Pytlik R, Necas E. Expression of genes regulating angiogenesis in human circulating hematopoietic cord blood CD34+/CD133+ cells. Eur J Haematol. 2003;70:143–50.
   PubMedGoogle Scholar
• Popa ER, Harmsen MC, Tio RA, van der Strate BW, Brouwer LA, Schipper M, . Circulating CD34+ progenitor cells modulate host angiogenesis and inflammation in vivo. J Mol Cell Cardiol. 2006;41:86–96.
   PubMed Web of Science ®Google Scholar
• Taguchi A, Soma T, Tanaka H, Kanda T, Nishimura H, Yoshikawa H, . Administration of CD34+ cells after stroke enhances neurogenesis via angiogenesis in a mouse model. J Clin Invest. 2004;114:330–8.
   PubMed Web of Science ®Google Scholar
• Bougioukas I, Didilis V, Ypsilantis P, Giatromanolaki A, Sivridis E, Lialiaris T, . Intramyocardial injection of low-dose basic fibroblast growth factor or vascular endothelial growth factor induces angiogenesis in the infarcted rabbit myocardium. Cardiovasc Pathol. 2007;16:63–8.
   PubMed Web of Science ®Google Scholar
• Ripa RS, Wang Y, Jorgensen E, Johnsen HE, Hesse B, Kastrup J. Intramyocardial injection of vascular endothelial growth factor-A165 plasmid followed by granulocyte-colony stimulating factor to induce angiogenesis in patients with severe chronic ischaemic heart disease. Eur Heart J. 2006;27:1785–92.
   PubMed Web of Science ®Google Scholar
• Schwarz ER, Speakman MT, Patterson M, Hale SS, Isner JM, Kedes LH, . Evaluation of the effects of intramyocardial injection of DNA expressing vascular endothelial growth factor (VEGF) in a myocardial infarction model in the rat: angiogenesis and angioma formation. J Am Coll Cardiol. 2000;35:1323–30.
   PubMed Web of Science ®Google Scholar
• Kawamoto A, Iwasaki H, Kusano K, Murayama T, Oyamada A, Silver M, . CD34-positive cells exhibit increased potency and safety for therapeutic neovascularization after myocardial infarction compared with total mononuclear cells. Circulation. 2006;114:2163–9.
   PubMed Web of Science ®Google Scholar
• Koyanagi M, Bushoven P, Iwasaki M, Urbich C, Zeiher AM, Dimmeler S. Notch signaling contributes to the expression of cardiac markers in human circulating progenitor cells. Circ Res. 2007;101:1139–45.
   PubMed Web of Science ®Google Scholar
• Fernandez L, Rodriguez S, Huang H, Chora A, Fernandes J, Mumaw C, . Tumor necrosis factor-alpha and endothelial cells modulate Notch signaling in the bone marrow microenvironment during inflammation. Exp Hematol. 2008;36:545–58.
   Google Scholar
• Paz H, Wong CA, Li W, Santat L, Wong KK, Chatterjee S. Quiescent subpopulations of human CD34-positive hematopoietic stem cells are preferred targets for stable recombinant adeno-associated virus type 2 transduction. Hum Gene Ther. 2007;18:614–26.
   Google Scholar
• Fukuda S, Pelus LM. Elevation of Survivin levels by hematopoietic growth factors occurs in quiescent CD34+ hematopoietic stem and progenitor cells before cell cycle entry. Cell Cycle (TX). 2002;1:322–6.
   PubMed Web of Science ®Google Scholar
• Jetmore A, Plett PA, Tong X, Wolber FM, Breese R, Abonour R, . Homing efficiency, cell cycle kinetics, and survival of quiescent and cycling human CD34(+) cells transplanted into conditioned NOD/SCID recipients. Blood. 2002;99:1585–93.
   PubMed Web of Science ®Google Scholar
• Shah AJ, Smogorzewska EM, Hannum C, Crooks GM. Flt3 ligand induces proliferation of quiescent human bone marrow CD34+CD38− cells and maintains progenitor cells in vitro. Blood. 1996;87:3563–70.
   PubMed Web of Science ®Google Scholar
• Yamamoto K, Takahashi T, Asahara T, Ohura N, Sokabe T, Kamiya A, . Proliferation, differentiation, and tube formation by endothelial progenitor cells in response to shear stress. J Appl Physiol. 2003;95:2081–8.
   PubMed Web of Science ®Google Scholar
• Murayama T, Tepper OM, Silver M, Ma H, Losordo DW, Isner JM, . Determination of bone marrow-derived endothelial progenitor cell significance in angiogenic growth factor-induced neovascularization in vivo. Exp Hematol. 2002;30:967–72.
   PubMed Web of Science ®Google Scholar
• O'Donnell PV, Myers B, Edwards J, Loper K, Rhubart P, Noga SJ. CD34 selection using three immunoselection devices: comparison of T-cell depleted allografts. Cytotherapy. 2001;3:483–8.
   PubMed Web of Science ®Google Scholar
• McNiece IK, Stoney GB, Kern BP, Briddell RA. CD34+ cell selection from frozen cord blood products using the Isolex 300i and CliniMACS CD34 selection devices. J Hematother. 1998;7:457–61.
   PubMedGoogle Scholar
• Watts MJ, Somervaille TC, Ings SJ, Ahmed F, Khwaja A, Yong K, . Variable product purity and functional capacity after CD34 selection: a direct comparison of the CliniMACS (v2.1) and Isolex 300i (v2.5) clinical scale devices. Br J Haematol. 2002;118:117–23.
   PubMed Web of Science ®Google Scholar